![Mark Day](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Day
Director/Miembro de la Junta en Aeromics, Inc. .
Cargos activos de Mark Day
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Aeromics, Inc.
![]() Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | Director/Miembro de la Junta | 16/08/2018 | - |
Historial de carrera de Mark Day
Antiguos cargos conocidos de Mark Day.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
NANOVIRICIDES, INC. | Director/Miembro de la Junta | 06/06/2019 | 29/05/2020 |
Independent Dir/Board Member | 06/06/2019 | 29/05/2020 | |
BIOASIS TECHNOLOGIES INC. | Director/Miembro de la Junta | 24/04/2017 | 11/03/2019 |
Director Ejecutivo | 24/04/2017 | 11/03/2019 | |
Presidente | 24/04/2017 | 11/03/2019 | |
Purdue Pharma (Canada)
![]() Purdue Pharma (Canada) Pharmaceuticals: MajorHealth Technology Purdue Pharma (Canada) manufactures and markets pharmaceutical products. It products for the treatment of pain, respiratory disease, gastrointestinal disorders, and infection control. The firm include laxatives, bronchodilators, antiseptics, and analgesics. Purdue Pharma is headquartered in Pickering, Canada | Corporate Officer/Principal | 01/10/2016 | 01/04/2017 |
ALEXION PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 01/06/2014 | 01/10/2016 |
Corporate Officer/Principal | 01/06/2014 | 01/10/2016 | |
Abbott Laboratories, Inc.
![]() Abbott Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Inc., the company manufactures and wholesales diagnostic and pharmaceutical products as well as medical devices. The company is based in Chicago, IL. | Corporate Officer/Principal | - | - |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
Formación de Mark Day.
University of Cardiff | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Reino Unido | 2 |
Canadá | 2 |
Operativa
Corporate Officer/Principal | 4 |
Director/Board Member | 4 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 8 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
BIOASIS TECHNOLOGIES INC. | Health Technology |
NANOVIRICIDES, INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Empresas privadas | 4 |
---|---|
Purdue Pharma (Canada)
![]() Purdue Pharma (Canada) Pharmaceuticals: MajorHealth Technology Purdue Pharma (Canada) manufactures and markets pharmaceutical products. It products for the treatment of pain, respiratory disease, gastrointestinal disorders, and infection control. The firm include laxatives, bronchodilators, antiseptics, and analgesics. Purdue Pharma is headquartered in Pickering, Canada | Health Technology |
Alexion Pharmaceuticals, Inc.
![]() Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Aeromics, Inc.
![]() Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | Health Technology |
Abbott Laboratories, Inc.
![]() Abbott Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Inc., the company manufactures and wholesales diagnostic and pharmaceutical products as well as medical devices. The company is based in Chicago, IL. | Health Technology |
- Bolsa de valores
- Insiders
- Mark Day
- Experiencia